FDA Adverse Event Injury Summary report: N

INTERSTIM

MDR report key: 1250368 · Received December 3, 2008

Report

Report Number
2182207-2008-07969
Event Type
Injury
Date Received
December 3, 2008
Report Date
November 6, 2008
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
EZW
PMA / PMN Number
P970004
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

JOURNAL REFERENCE: FAUCHERON JL, BOST R, DUFFOURNET V, DUPUY S, CARDIN N, BONAZ B, SACRAL NEUROMODULATION IN THE TREATMENT OF SEVERE ANAL INCONTINENCE. FORTY CONSECUTIVE CASES TREATED IN ONE INSTITUTION, GASTROENTEROL CLIN BIOL. MAY 2006;30(5): 669-672. SACRAL NEUROMODULATION IS A RECOGNIZED THERAPEUTIC OPTION IN SEVERE ANAL INCONTINENCE FROM NEUROGENIC ORIGINS, WHEN MEDICAL TREATMENT HAS FAILED. TWENTY NINE PATIENTS HAD A POSITIVE TEST AND WERE IMPLANTED. REPORTABLE EVENT: THE LAST COMPLICATION IN A PATIENT OCCURRED WHEN THE NEUROSTIMULATOR LOST ITS CHANGE PREMATURELY, SO THAT IT HAD TO BE REPLACED ALONG WITH A NEW ELECTRODE, 3 YEARS AND FIVE MONTHS AFTER THE FIRST IMPLANTATION. SEE MFG REPORT # 2182207-2008-07948.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INTERSTIM EZW MEDTRONIC NEUROMODULATION 3023 NA

Patients

Seq Age Sex Outcome Treatment
1 UNK Hospitalization EXTENSION: MODEL UNK N=1| LEAD: MODEL UNK N=1| PROGRAMMER: MODEL UNK N=1